Acacia Dealbata, Acer Negundo, Populus Fremontii, Olea Europaea, Ulmus Pumila, Betula Occidentalis, Juniperus Occidentalis, Platanus Racemosa, Quercus Garryana And Morus Alba
Generic Name: acacia dealbata, acer negundo, populus fremontii, olea europaea, ulmus pumila, betula occidentalis, juniperus occidentalis, platanus racemosa, quercus garryana and morus alba
Brand Names:
Western 10 Tree Pollen Mix
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ACACIA DEALBATA POLLEN (.01 g/mL); ACER NEGUNDO POLLEN (.01 g/mL); BETULA OCCIDENTALIS POLLEN (.01 g/mL); JUNIPERUS OCCIDENTALIS POLLEN (.01 g/mL); MORUS ALBA POLLEN (.01 g/mL); OLEA EUROPAEA POLLEN (.01 g/mL); PLATANUS RACEMOSA POLLEN (.01 g/mL); POPULUS FREMONTII POLLEN (.01 g/mL); QUERCUS GARRYANA POLLEN (.01 g/mL); ULMUS PUMILA POLLEN (.01 g/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ACACIA DEALBATA POLLEN (.01 g/mL); ACER NEGUNDO POLLEN (.01 g/mL); BETULA OCCIDENTALIS POLLEN (.01 g/mL); JUNIPERUS OCCIDENTALIS POLLEN (.01 g/mL); MORUS ALBA POLLEN (.01 g/mL); OLEA EUROPAEA POLLEN (.01 g/mL); PLATANUS RACEMOSA POLLEN (.01 g/mL); POPULUS FREMONTII POLLEN (.01 g/mL); QUERCUS GARRYANA POLLEN (.01 g/mL); ULMUS PUMILA POLLEN (.01 g/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Sorafenib Tosylate
sorafenib tosylate
Dosage form: POWDER. Active ingredients: SORAFENIB TOSYLATE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Centaurium Umbellatum, Flos
centaurium umbellatum, flos
INDICATIONS: For temporary relief of weak-willed overreaction to the wishes of others; good-natured, easily exploited, can't say no.
Trastuzumab-qyyp
trastuzumab-qyyp
HER2/neu Receptor Antagonist [EPC]
11 DESCRIPTION Trastuzumab-qyyp is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-qyyp is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. TRAZIMERA (trastuzumab-qyyp) for injection is a sterile, white, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.